This tells you something important about early dosing too
This gives your gut microbiome time to adjust to the new fuel you are providing
In people with type 2 diabetes and those at high risk for heart disease, it lowered the risk of major events like heart attack and stroke
Participants taking the highest dose (15 mg) lost an average of 22.5% of their body weight over 72 weeks, compared to 2.4% with placebo
Reviewing the Clinical Trial Data on Retatrutide The current evidence base around retatrutide is promising enough to justify continued development, but it still needs to be read as investigational clinical trial evidence , not as proof of guaranteed real-world outcomes for UK patients
Concurrently, the glucose-lowering strategy has evolved from solely managing hyperglycemia to emphasizing comprehensive, long-term patient benefits